Metraipolis › archive › dc_7ef40e379792
Revisiting the OGIPRO Trial: Dynamic Electronic Patient-Reported Outcomes Compared with EQ-5D-5L in HER2-Positive Breast Cancer — Europe PMC PMID:41749867
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41749867
- DOI
- 10.3390/cancers18040614
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T20:30:17.126Z
- SHA-256 of the archived text
3d7abfd11d1c35132643c4cfd94688d8d97f513ec45d3226bec48be3b190eabc- Stable URL of this page
https://metraipolis.com/documento/dc_7ef40e379792
How to cite
Revisiting the OGIPRO Trial: Dynamic Electronic Patient-Reported Outcomes Compared with EQ-5D-5L in HER2-Positive Breast Cancer — Europe PMC PMID:41749867 — Europe PMC (en), https://europepmc.org/article/MED/41749867 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7ef40e379792 (Metraipolis archive dc_7ef40e379792, sha256 3d7abfd11d1c35132643c4cfd94688d8d97f513ec45d3226bec48be3b190eabc)
BibTeX
@misc{dc7ef40e379792,
title = {Revisiting the OGIPRO Trial: Dynamic Electronic Patient-Reported Outcomes Compared with EQ-5D-5L in HER2-Positive Breast Cancer — Europe PMC PMID:41749867},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41749867},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7ef40e379792; sha256 3d7abfd11d1c35132643c4cfd94688d8d97f513ec45d3226bec48be3b190eabc},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41749867. Agents can read the archived copy with the MCP tool read_document.